Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$41.56 - $59.88 $3.76 Million - $5.42 Million
-90,465 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$36.08 - $56.47 $1.11 Million - $1.73 Million
-30,632 Reduced 25.3%
90,465 $4.87 Million
Q3 2020

Nov 13, 2020

BUY
$33.26 - $40.48 $55,444 - $67,480
1,667 Added 1.4%
121,097 $4.47 Million
Q2 2020

Aug 13, 2020

SELL
$24.21 - $31.02 $926,855 - $1.19 Million
-38,284 Reduced 24.27%
119,430 $3.7 Million
Q1 2020

May 12, 2020

SELL
$20.5 - $34.53 $97,170 - $163,672
-4,740 Reduced 2.92%
157,714 $4.35 Million
Q4 2019

Feb 06, 2020

BUY
$18.96 - $29.84 $221,794 - $349,068
11,698 Added 7.76%
162,454 $4.75 Million
Q3 2019

Nov 05, 2019

SELL
$19.12 - $26.24 $17,915 - $24,586
-937 Reduced 0.62%
150,756 $2.88 Million
Q2 2019

Aug 06, 2019

SELL
$19.57 - $24.1 $2.31 Million - $2.84 Million
-117,795 Reduced 43.71%
151,693 $3.33 Million
Q1 2019

May 14, 2019

SELL
$12.14 - $20.46 $321,442 - $541,739
-26,478 Reduced 8.95%
269,488 $5.51 Million
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $711,817 - $1.17 Million
-63,329 Reduced 17.63%
295,966 $3.73 Million
Q3 2018

Nov 14, 2018

SELL
$12.5 - $15.38 $15,475 - $19,040
-1,238 Reduced 0.34%
359,295 $5.52 Million
Q2 2018

Aug 14, 2018

SELL
$7.99 - $14.05 $33,805 - $59,445
-4,231 Reduced 1.16%
360,533 $4.73 Million
Q1 2018

May 14, 2018

SELL
$7.23 - $8.76 $75,755 - $91,787
-10,478 Reduced 2.79%
364,764 $2.98 Million
Q4 2017

Feb 14, 2018

SELL
$8.02 - $11.18 $17,467 - $24,350
-2,178 Reduced 0.58%
375,242 $3.33 Million
Q3 2017

Nov 09, 2017

BUY
$9.11 - $11.26 $3.44 Million - $4.25 Million
377,420
377,420 $4.2 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.71B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.